RE-BVS – Piemonte Repository

Sfoglia per AUTORE
WU K
Collezione AOU Città della Salute di Torino

Items : 6

The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography to Magnetic Resonance Imaging for Local Staging of Prostate Cancer in Patients Undergoing Radical Prostatectomy. in European urology oncology / Eur Urol Oncol. 2024 Nov 28:S2588-9311(24)00249-9. doi: 10.1016/j.euo.2024.11.002.

2024
AOU Città della Salute di Torino

Soeterik TFW; Heetman JG; Hermsen R; Wever L; Lavalaye J; Vinken M; Bahler CD; Yong C; Tann M; Kesch C; Seifert R; Telli T; Chiu PK; Wu KK; Zattoni F; Evangelista L; Bettella S; Ceci F; Barone A; Miszczyk M; Matsukawa A; Rajwa P; Marra G; Briganti A; Montorsi F; Scheltema MJ; van Basten JA; van Melick HHE; van den Bergh RCN; et alii...

The association of quantitative PSMA PET parameters with pathologic ISUP grade: an international multicenter analysis. in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):314-325. doi: 10.1007/s00259-024-06847-y. Epub 2024 Aug 1

2024
AOU Città della Salute di Torino

Mazzone E; Marra G; Rajwa P; Ceci F; Barone A; Segalla E; Evangelista L; Zattoni F; Chiu PK; Wu KK; Telli T; Seifert R; Kesch C; Tann M; Yong C; Bahler CD; Vinken M; Lavalaye J; Wever L; Hermsen R; Heetman JG; Soeterik TFW; Van Basten JA; Van Melick HHE; Van den Bergh RCN; Gandaglia G;

Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study. in The Lancet. Oncology / Lancet Oncol. 2023 Oct;24(10):1119-1133. doi: 10.1016/S1470-2045(23)00405-9. Epub 2023 Sep 14.

2023
AOU Città della Salute di Torino

Benjamin R; Hájek R; Zweegman S; Silkjaer T; Caers J; Mancuso K; Tacchetti P; Razawy W; Grasso M; Giaccone L; Offidani M; Lund T; van der Velden VHJ; Pour L; Gadisseur A; Pietrantuono G; Broijl A; Roeloffzen WWH; Wu KL; Schjesvold F; van der Holt B; Minnema MC; van de Donk NWCJ; Vangsted AJ; Boccadoro M; Gay F; Sonneveld P; Musto P;

Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma. in HemaSphere / Hemasphere. 2022 Sep 30;6(10):e786. doi: 10.1097/HS9.0000000000000786. eCollection 2022 Oct.

2022
AOU Città della Salute di Torino

Sonneveld P; Zweegman S; Cavo M; Nasserinejad K; Broijl A; Troia R; Pour L; Croockewit S; Corradini P; Patriarca F; Wu K; Droogendijk J; Bos G; Hajek R; Teresa Petrucci M; Ypma P; Zojer N; Minnema MC; Boccadoro M;

Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Nov 10;39(32):3613-3622. doi: 10.1200/JCO.21.01045. Epub 2021 Sep 14.

2021
AOU Città della Salute di Torino

Sonneveld P; Dimopoulos MA; Beksac M; van der Holt B; Aquino S; Ludwig H; Zweegman S; Zander T; Zamagni E; Wester R; Hajek R; Pantani L; Dozza L; Gay F; Cafro A; De Rosa L; Morelli A; Gregersen H; Gulbrandsen N; Cornelisse P; Troia R; Oliva S; van de Velden V; Wu K; Ypma PF; Bos G; Levin MD; Pour L; Driessen C; et alii...

Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study. in The Lancet. Haematology / Lancet Haematol. 2020 Jun;7(6):e456-e468. doi: 10.1016/S2352-3026(20)30099-5. Epub 2020 Apr 30.

2020
AOU Città della Salute di Torino

Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; et alii...